Using causal machine learning and real world data to improve dose response decision making for secukinumab in psoriatic arthritis
Crossref DOI link: https://doi.org/10.1038/s41598-026-47976-8
Published Online: 2026-04-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kiltz, Uta
Glassen, Thomas
Brandt-Juergens, Jan
Kiss, Ferenc
Peterlik, Daniel
Gmeiner, Benjamin
Text and Data Mining valid from 2026-04-11
Version of Record valid from 2026-04-13
Article History
Received: 6 May 2025
Accepted: 6 April 2026
First Online: 11 April 2026
Declarations
:
: The authors declare no competing interests.